nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—CYP2C9—brain cancer	0.705	1	CbGaD
Mefenamic acid—PTGS2—Etoposide—brain cancer	0.0468	0.429	CbGbCtD
Mefenamic acid—PTGS1—Etoposide—brain cancer	0.0395	0.362	CbGbCtD
Mefenamic acid—CYP2C8—Etoposide—brain cancer	0.0228	0.209	CbGbCtD
Mefenamic acid—AKR1C3—Podofilox—Etoposide—brain cancer	0.00433	1	CbGdCrCtD
Mefenamic acid—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00199	0.0565	CbGpPWpGaD
Mefenamic acid—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00179	0.0508	CbGpPWpGaD
Mefenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00168	0.0476	CbGpPWpGaD
Mefenamic acid—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00163	0.0462	CbGpPWpGaD
Mefenamic acid—Acetylsalicylic acid—TP53—brain cancer	0.00148	0.263	CrCbGaD
Mefenamic acid—AKR1C3—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00147	0.0417	CbGpPWpGaD
Mefenamic acid—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00139	0.0394	CbGpPWpGaD
Mefenamic acid—PTGS2—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00133	0.0378	CbGpPWpGaD
Mefenamic acid—Lumiracoxib—CYP2C9—brain cancer	0.00125	0.222	CrCbGaD
Mefenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00116	0.033	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metapathway biotransformation—CYP2C9—brain cancer	0.00109	0.031	CbGpPWpGaD
Mefenamic acid—PTGS2—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000923	0.0262	CbGpPWpGaD
Mefenamic acid—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000861	0.0244	CbGpPWpGaD
Mefenamic acid—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000828	0.0235	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metapathway biotransformation—CYP2C9—brain cancer	0.000803	0.0227	CbGpPWpGaD
Mefenamic acid—Acetylsalicylic acid—CYP2C9—brain cancer	0.000736	0.131	CrCbGaD
Mefenamic acid—Deafness—Temozolomide—brain cancer	0.000681	0.00496	CcSEcCtD
Mefenamic acid—Decreased appetite—Lomustine—brain cancer	0.000678	0.00494	CcSEcCtD
Mefenamic acid—Hepatic failure—Temozolomide—brain cancer	0.000678	0.00494	CcSEcCtD
Mefenamic acid—Pancreatitis—Hydroxyurea—brain cancer	0.000661	0.00482	CcSEcCtD
Mefenamic acid—Dermatitis exfoliative—Temozolomide—brain cancer	0.000646	0.0047	CcSEcCtD
Mefenamic acid—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000641	0.0182	CbGpPWpGaD
Mefenamic acid—Pancytopenia—Hydroxyurea—brain cancer	0.00064	0.00466	CcSEcCtD
Mefenamic acid—Hyponatraemia—Carmustine—brain cancer	0.000633	0.00461	CcSEcCtD
Mefenamic acid—Purpura—Temozolomide—brain cancer	0.000632	0.00461	CcSEcCtD
Mefenamic acid—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00063	0.00459	CcSEcCtD
Mefenamic acid—Dysuria—Hydroxyurea—brain cancer	0.00063	0.00459	CcSEcCtD
Mefenamic acid—Arrhythmia—Procarbazine—brain cancer	0.000623	0.00454	CcSEcCtD
Mefenamic acid—Body temperature increased—Lomustine—brain cancer	0.000617	0.00449	CcSEcCtD
Mefenamic acid—Alopecia—Procarbazine—brain cancer	0.000616	0.00449	CcSEcCtD
Mefenamic acid—Oesophagitis—Etoposide—brain cancer	0.000614	0.00447	CcSEcCtD
Mefenamic acid—Salicylic acid—CYP2C9—brain cancer	0.000606	0.108	CrCbGaD
Mefenamic acid—Drowsiness—Hydroxyurea—brain cancer	0.000601	0.00438	CcSEcCtD
Mefenamic acid—Tension—Procarbazine—brain cancer	0.000596	0.00434	CcSEcCtD
Mefenamic acid—Nervousness—Procarbazine—brain cancer	0.000589	0.00429	CcSEcCtD
Mefenamic acid—Stomatitis—Hydroxyurea—brain cancer	0.000586	0.00427	CcSEcCtD
Mefenamic acid—Sepsis—Etoposide—brain cancer	0.000583	0.00425	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Carmustine—brain cancer	0.000582	0.00424	CcSEcCtD
Mefenamic acid—Tremor—Procarbazine—brain cancer	0.000569	0.00414	CcSEcCtD
Mefenamic acid—Anaemia—Procarbazine—brain cancer	0.000561	0.00409	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000549	0.004	CcSEcCtD
Mefenamic acid—Syncope—Procarbazine—brain cancer	0.000544	0.00397	CcSEcCtD
Mefenamic acid—Leukopenia—Procarbazine—brain cancer	0.000543	0.00396	CcSEcCtD
Mefenamic acid—Diclofenac—CYP2C9—brain cancer	0.000543	0.0966	CrCbGaD
Mefenamic acid—Haemoglobin—Hydroxyurea—brain cancer	0.000542	0.00395	CcSEcCtD
Mefenamic acid—AKR1C3—Metapathway biotransformation—CYP2C9—brain cancer	0.00054	0.0153	CbGpPWpGaD
Mefenamic acid—Haemorrhage—Hydroxyurea—brain cancer	0.00054	0.00393	CcSEcCtD
Mefenamic acid—Cardiac failure congestive—Etoposide—brain cancer	0.000538	0.00392	CcSEcCtD
Mefenamic acid—Hallucination—Hydroxyurea—brain cancer	0.000537	0.00391	CcSEcCtD
Mefenamic acid—Loss of consciousness—Procarbazine—brain cancer	0.000533	0.00389	CcSEcCtD
Mefenamic acid—Flurbiprofen—CYP2C9—brain cancer	0.000531	0.0946	CrCbGaD
Mefenamic acid—Convulsion—Procarbazine—brain cancer	0.000526	0.00383	CcSEcCtD
Mefenamic acid—Hypertension—Procarbazine—brain cancer	0.000524	0.00382	CcSEcCtD
Mefenamic acid—Pancytopenia—Carmustine—brain cancer	0.000517	0.00377	CcSEcCtD
Mefenamic acid—Anxiety—Procarbazine—brain cancer	0.000515	0.00375	CcSEcCtD
Mefenamic acid—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000509	0.0144	CbGpPWpGaD
Mefenamic acid—Dry mouth—Procarbazine—brain cancer	0.000505	0.00368	CcSEcCtD
Mefenamic acid—Anaphylactoid reaction—Etoposide—brain cancer	0.000504	0.00367	CcSEcCtD
Mefenamic acid—Pancytopenia—Temozolomide—brain cancer	0.0005	0.00364	CcSEcCtD
Mefenamic acid—Confusional state—Procarbazine—brain cancer	0.000499	0.00364	CcSEcCtD
Mefenamic acid—Vomiting—Lomustine—brain cancer	0.000496	0.00361	CcSEcCtD
Mefenamic acid—Oedema—Procarbazine—brain cancer	0.000495	0.00361	CcSEcCtD
Mefenamic acid—Dysuria—Temozolomide—brain cancer	0.000492	0.00359	CcSEcCtD
Mefenamic acid—Infection—Procarbazine—brain cancer	0.000492	0.00359	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Carmustine—brain cancer	0.000492	0.00358	CcSEcCtD
Mefenamic acid—Pneumonia—Carmustine—brain cancer	0.000489	0.00356	CcSEcCtD
Mefenamic acid—Shock—Procarbazine—brain cancer	0.000487	0.00355	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Procarbazine—brain cancer	0.000485	0.00353	CcSEcCtD
Mefenamic acid—Tachycardia—Procarbazine—brain cancer	0.000483	0.00352	CcSEcCtD
Mefenamic acid—Ketoprofen—CYP2C9—brain cancer	0.000481	0.0855	CrCbGaD
Mefenamic acid—Photosensitivity reaction—Temozolomide—brain cancer	0.000481	0.0035	CcSEcCtD
Mefenamic acid—Renal failure—Carmustine—brain cancer	0.000478	0.00348	CcSEcCtD
Mefenamic acid—Alopecia—Hydroxyurea—brain cancer	0.000477	0.00347	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Temozolomide—brain cancer	0.000475	0.00346	CcSEcCtD
Mefenamic acid—Stomatitis—Carmustine—brain cancer	0.000474	0.00345	CcSEcCtD
Mefenamic acid—Pneumonia—Temozolomide—brain cancer	0.000472	0.00344	CcSEcCtD
Mefenamic acid—Anorexia—Procarbazine—brain cancer	0.000472	0.00344	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000465	0.00339	CcSEcCtD
Mefenamic acid—Nausea—Lomustine—brain cancer	0.000463	0.00338	CcSEcCtD
Mefenamic acid—Hypotension—Procarbazine—brain cancer	0.000463	0.00337	CcSEcCtD
Mefenamic acid—Stomatitis—Temozolomide—brain cancer	0.000458	0.00333	CcSEcCtD
Mefenamic acid—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000449	0.0127	CbGpPWpGaD
Mefenamic acid—Insomnia—Procarbazine—brain cancer	0.000448	0.00326	CcSEcCtD
Mefenamic acid—Paraesthesia—Procarbazine—brain cancer	0.000445	0.00324	CcSEcCtD
Mefenamic acid—Somnolence—Procarbazine—brain cancer	0.00044	0.00321	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000439	0.0032	CcSEcCtD
Mefenamic acid—Haemoglobin—Carmustine—brain cancer	0.000438	0.00319	CcSEcCtD
Mefenamic acid—Haemorrhage—Carmustine—brain cancer	0.000436	0.00318	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Hydroxyurea—brain cancer	0.000436	0.00318	CcSEcCtD
Mefenamic acid—Anaemia—Hydroxyurea—brain cancer	0.000434	0.00316	CcSEcCtD
Mefenamic acid—Hallucination—Carmustine—brain cancer	0.000434	0.00316	CcSEcCtD
Mefenamic acid—Decreased appetite—Procarbazine—brain cancer	0.000431	0.00314	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000426	0.0121	CbGpPWpGaD
Mefenamic acid—Haemoglobin—Temozolomide—brain cancer	0.000424	0.00309	CcSEcCtD
Mefenamic acid—Malaise—Hydroxyurea—brain cancer	0.000424	0.00309	CcSEcCtD
Mefenamic acid—Constipation—Procarbazine—brain cancer	0.000424	0.00309	CcSEcCtD
Mefenamic acid—Hepatitis—Temozolomide—brain cancer	0.000421	0.00307	CcSEcCtD
Mefenamic acid—Haemorrhage—Temozolomide—brain cancer	0.000421	0.00307	CcSEcCtD
Mefenamic acid—Leukopenia—Hydroxyurea—brain cancer	0.00042	0.00306	CcSEcCtD
Mefenamic acid—Hallucination—Temozolomide—brain cancer	0.000419	0.00306	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Temozolomide—brain cancer	0.000416	0.00303	CcSEcCtD
Mefenamic acid—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000414	0.0117	CbGpPWpGaD
Mefenamic acid—Urethral disorder—Temozolomide—brain cancer	0.000413	0.00301	CcSEcCtD
Mefenamic acid—Feeling abnormal—Procarbazine—brain cancer	0.000408	0.00297	CcSEcCtD
Mefenamic acid—Convulsion—Hydroxyurea—brain cancer	0.000407	0.00296	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Procarbazine—brain cancer	0.000405	0.00295	CcSEcCtD
Mefenamic acid—Pancytopenia—Etoposide—brain cancer	0.0004	0.00292	CcSEcCtD
Mefenamic acid—Erythema multiforme—Temozolomide—brain cancer	0.000399	0.0029	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000397	0.00289	CcSEcCtD
Mefenamic acid—Discomfort—Hydroxyurea—brain cancer	0.000395	0.00288	CcSEcCtD
Mefenamic acid—Urticaria—Procarbazine—brain cancer	0.000393	0.00287	CcSEcCtD
Mefenamic acid—Tinnitus—Temozolomide—brain cancer	0.000393	0.00286	CcSEcCtD
Mefenamic acid—Body temperature increased—Procarbazine—brain cancer	0.000392	0.00285	CcSEcCtD
Mefenamic acid—Abdominal pain—Procarbazine—brain cancer	0.000392	0.00285	CcSEcCtD
Mefenamic acid—Arrhythmia—Carmustine—brain cancer	0.00039	0.00284	CcSEcCtD
Mefenamic acid—Alopecia—Carmustine—brain cancer	0.000385	0.00281	CcSEcCtD
Mefenamic acid—Oedema—Hydroxyurea—brain cancer	0.000383	0.00279	CcSEcCtD
Mefenamic acid—Mental disorder—Carmustine—brain cancer	0.000382	0.00278	CcSEcCtD
Mefenamic acid—Infection—Hydroxyurea—brain cancer	0.000381	0.00277	CcSEcCtD
Mefenamic acid—Pneumonia—Etoposide—brain cancer	0.000378	0.00275	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Hydroxyurea—brain cancer	0.000375	0.00273	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000372	0.00271	CcSEcCtD
Mefenamic acid—Alopecia—Temozolomide—brain cancer	0.000372	0.00271	CcSEcCtD
Mefenamic acid—Skin disorder—Hydroxyurea—brain cancer	0.000372	0.00271	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Etoposide—brain cancer	0.00037	0.0027	CcSEcCtD
Mefenamic acid—Renal failure—Etoposide—brain cancer	0.000369	0.00269	CcSEcCtD
Mefenamic acid—Mental disorder—Temozolomide—brain cancer	0.000369	0.00269	CcSEcCtD
Mefenamic acid—Myocardial infarction—Etoposide—brain cancer	0.000368	0.00268	CcSEcCtD
Mefenamic acid—Stomatitis—Etoposide—brain cancer	0.000366	0.00267	CcSEcCtD
Mefenamic acid—Jaundice—Etoposide—brain cancer	0.000366	0.00267	CcSEcCtD
Mefenamic acid—Anorexia—Hydroxyurea—brain cancer	0.000365	0.00266	CcSEcCtD
Mefenamic acid—Vision blurred—Carmustine—brain cancer	0.000358	0.00261	CcSEcCtD
Mefenamic acid—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000358	0.0101	CbGpPWpGaD
Mefenamic acid—Tremor—Carmustine—brain cancer	0.000356	0.00259	CcSEcCtD
Mefenamic acid—Asthenia—Procarbazine—brain cancer	0.000355	0.00259	CcSEcCtD
Mefenamic acid—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000353	0.01	CbGpPWpGaD
Mefenamic acid—Anaemia—Carmustine—brain cancer	0.000351	0.00256	CcSEcCtD
Mefenamic acid—Agranulocytosis—Etoposide—brain cancer	0.000351	0.00255	CcSEcCtD
Mefenamic acid—Pruritus—Procarbazine—brain cancer	0.00035	0.00255	CcSEcCtD
Mefenamic acid—Vision blurred—Temozolomide—brain cancer	0.000346	0.00252	CcSEcCtD
Mefenamic acid—Tremor—Temozolomide—brain cancer	0.000344	0.0025	CcSEcCtD
Mefenamic acid—Dyspnoea—Hydroxyurea—brain cancer	0.000342	0.00249	CcSEcCtD
Mefenamic acid—Somnolence—Hydroxyurea—brain cancer	0.000341	0.00248	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Temozolomide—brain cancer	0.00034	0.00248	CcSEcCtD
Mefenamic acid—Leukopenia—Carmustine—brain cancer	0.00034	0.00248	CcSEcCtD
Mefenamic acid—Anaemia—Temozolomide—brain cancer	0.000339	0.00247	CcSEcCtD
Mefenamic acid—Diarrhoea—Procarbazine—brain cancer	0.000339	0.00247	CcSEcCtD
Mefenamic acid—Dyspepsia—Hydroxyurea—brain cancer	0.000337	0.00246	CcSEcCtD
Mefenamic acid—Angioedema—Temozolomide—brain cancer	0.000335	0.00244	CcSEcCtD
Mefenamic acid—Decreased appetite—Hydroxyurea—brain cancer	0.000333	0.00243	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Etoposide—brain cancer	0.000333	0.00243	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000331	0.00241	CcSEcCtD
Mefenamic acid—Malaise—Temozolomide—brain cancer	0.000331	0.00241	CcSEcCtD
Mefenamic acid—Urethral disorder—Etoposide—brain cancer	0.000331	0.00241	CcSEcCtD
Mefenamic acid—Vertigo—Temozolomide—brain cancer	0.00033	0.0024	CcSEcCtD
Mefenamic acid—Convulsion—Carmustine—brain cancer	0.000329	0.0024	CcSEcCtD
Mefenamic acid—Leukopenia—Temozolomide—brain cancer	0.000328	0.00239	CcSEcCtD
Mefenamic acid—Hypertension—Carmustine—brain cancer	0.000328	0.00239	CcSEcCtD
Mefenamic acid—Constipation—Hydroxyurea—brain cancer	0.000328	0.00239	CcSEcCtD
Mefenamic acid—Dizziness—Procarbazine—brain cancer	0.000328	0.00239	CcSEcCtD
Mefenamic acid—Palpitations—Temozolomide—brain cancer	0.000324	0.00236	CcSEcCtD
Mefenamic acid—Anxiety—Carmustine—brain cancer	0.000322	0.00235	CcSEcCtD
Mefenamic acid—AKR1C2—brain—brain cancer	0.000319	0.1	CbGeAlD
Mefenamic acid—Erythema multiforme—Etoposide—brain cancer	0.000319	0.00232	CcSEcCtD
Mefenamic acid—Convulsion—Temozolomide—brain cancer	0.000318	0.00232	CcSEcCtD
Mefenamic acid—Hypertension—Temozolomide—brain cancer	0.000317	0.00231	CcSEcCtD
Mefenamic acid—Feeling abnormal—Hydroxyurea—brain cancer	0.000316	0.0023	CcSEcCtD
Mefenamic acid—Vomiting—Procarbazine—brain cancer	0.000315	0.00229	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000313	0.00886	CbGpPWpGaD
Mefenamic acid—Confusional state—Carmustine—brain cancer	0.000312	0.00228	CcSEcCtD
Mefenamic acid—Rash—Procarbazine—brain cancer	0.000312	0.00228	CcSEcCtD
Mefenamic acid—Dermatitis—Procarbazine—brain cancer	0.000312	0.00227	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000311	0.00882	CbGpPWpGaD
Mefenamic acid—Anxiety—Temozolomide—brain cancer	0.000311	0.00227	CcSEcCtD
Mefenamic acid—Headache—Procarbazine—brain cancer	0.00031	0.00226	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00031	0.00226	CcSEcCtD
Mefenamic acid—Oedema—Carmustine—brain cancer	0.00031	0.00226	CcSEcCtD
Mefenamic acid—Discomfort—Temozolomide—brain cancer	0.000309	0.00225	CcSEcCtD
Mefenamic acid—Infection—Carmustine—brain cancer	0.000308	0.00224	CcSEcCtD
Mefenamic acid—Dry mouth—Temozolomide—brain cancer	0.000305	0.00223	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Carmustine—brain cancer	0.000303	0.00221	CcSEcCtD
Mefenamic acid—Body temperature increased—Hydroxyurea—brain cancer	0.000303	0.00221	CcSEcCtD
Mefenamic acid—Tachycardia—Carmustine—brain cancer	0.000302	0.0022	CcSEcCtD
Mefenamic acid—Confusional state—Temozolomide—brain cancer	0.000302	0.0022	CcSEcCtD
Mefenamic acid—Oedema—Temozolomide—brain cancer	0.000299	0.00218	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Temozolomide—brain cancer	0.000299	0.00218	CcSEcCtD
Mefenamic acid—Alopecia—Etoposide—brain cancer	0.000298	0.00217	CcSEcCtD
Mefenamic acid—Infection—Temozolomide—brain cancer	0.000297	0.00217	CcSEcCtD
Mefenamic acid—Anorexia—Carmustine—brain cancer	0.000295	0.00215	CcSEcCtD
Mefenamic acid—Nausea—Procarbazine—brain cancer	0.000294	0.00214	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Temozolomide—brain cancer	0.000293	0.00214	CcSEcCtD
Mefenamic acid—Skin disorder—Temozolomide—brain cancer	0.000291	0.00212	CcSEcCtD
Mefenamic acid—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00029	0.00821	CbGpPWpGaD
Mefenamic acid—Hypotension—Carmustine—brain cancer	0.00029	0.00211	CcSEcCtD
Mefenamic acid—Anorexia—Temozolomide—brain cancer	0.000285	0.00208	CcSEcCtD
Mefenamic acid—Insomnia—Carmustine—brain cancer	0.00028	0.00204	CcSEcCtD
Mefenamic acid—Paraesthesia—Carmustine—brain cancer	0.000278	0.00203	CcSEcCtD
Mefenamic acid—Dyspnoea—Carmustine—brain cancer	0.000276	0.00201	CcSEcCtD
Mefenamic acid—Somnolence—Carmustine—brain cancer	0.000275	0.00201	CcSEcCtD
Mefenamic acid—Asthenia—Hydroxyurea—brain cancer	0.000275	0.002	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Etoposide—brain cancer	0.000272	0.00198	CcSEcCtD
Mefenamic acid—Anaemia—Etoposide—brain cancer	0.000271	0.00198	CcSEcCtD
Mefenamic acid—Insomnia—Temozolomide—brain cancer	0.000271	0.00197	CcSEcCtD
Mefenamic acid—Decreased appetite—Carmustine—brain cancer	0.000269	0.00196	CcSEcCtD
Mefenamic acid—Paraesthesia—Temozolomide—brain cancer	0.000269	0.00196	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Carmustine—brain cancer	0.000268	0.00195	CcSEcCtD
Mefenamic acid—Dyspnoea—Temozolomide—brain cancer	0.000267	0.00195	CcSEcCtD
Mefenamic acid—Somnolence—Temozolomide—brain cancer	0.000266	0.00194	CcSEcCtD
Mefenamic acid—Constipation—Carmustine—brain cancer	0.000265	0.00193	CcSEcCtD
Mefenamic acid—Malaise—Etoposide—brain cancer	0.000265	0.00193	CcSEcCtD
Mefenamic acid—Vertigo—Etoposide—brain cancer	0.000264	0.00192	CcSEcCtD
Mefenamic acid—Dyspepsia—Temozolomide—brain cancer	0.000264	0.00192	CcSEcCtD
Mefenamic acid—Leukopenia—Etoposide—brain cancer	0.000263	0.00191	CcSEcCtD
Mefenamic acid—Diarrhoea—Hydroxyurea—brain cancer	0.000262	0.00191	CcSEcCtD
Mefenamic acid—Decreased appetite—Temozolomide—brain cancer	0.00026	0.0019	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Temozolomide—brain cancer	0.000259	0.00188	CcSEcCtD
Mefenamic acid—Loss of consciousness—Etoposide—brain cancer	0.000258	0.00188	CcSEcCtD
Mefenamic acid—Constipation—Temozolomide—brain cancer	0.000256	0.00187	CcSEcCtD
Mefenamic acid—Feeling abnormal—Carmustine—brain cancer	0.000255	0.00186	CcSEcCtD
Mefenamic acid—Convulsion—Etoposide—brain cancer	0.000254	0.00185	CcSEcCtD
Mefenamic acid—Hypertension—Etoposide—brain cancer	0.000253	0.00185	CcSEcCtD
Mefenamic acid—Dizziness—Hydroxyurea—brain cancer	0.000253	0.00185	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Carmustine—brain cancer	0.000253	0.00185	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000248	0.00181	CcSEcCtD
Mefenamic acid—Discomfort—Etoposide—brain cancer	0.000247	0.0018	CcSEcCtD
Mefenamic acid—Feeling abnormal—Temozolomide—brain cancer	0.000247	0.0018	CcSEcCtD
Mefenamic acid—AKR1C1—Disease—DTX2—brain cancer	0.000246	0.00697	CbGpPWpGaD
Mefenamic acid—Abdominal pain—Carmustine—brain cancer	0.000245	0.00178	CcSEcCtD
Mefenamic acid—Body temperature increased—Carmustine—brain cancer	0.000245	0.00178	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Temozolomide—brain cancer	0.000245	0.00178	CcSEcCtD
Mefenamic acid—Vomiting—Hydroxyurea—brain cancer	0.000244	0.00178	CcSEcCtD
Mefenamic acid—Rash—Hydroxyurea—brain cancer	0.000242	0.00176	CcSEcCtD
Mefenamic acid—Confusional state—Etoposide—brain cancer	0.000242	0.00176	CcSEcCtD
Mefenamic acid—Dermatitis—Hydroxyurea—brain cancer	0.000241	0.00176	CcSEcCtD
Mefenamic acid—Headache—Hydroxyurea—brain cancer	0.00024	0.00175	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Etoposide—brain cancer	0.00024	0.00175	CcSEcCtD
Mefenamic acid—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000238	0.00676	CbGpPWpGaD
Mefenamic acid—Infection—Etoposide—brain cancer	0.000238	0.00173	CcSEcCtD
Mefenamic acid—Urticaria—Temozolomide—brain cancer	0.000238	0.00173	CcSEcCtD
Mefenamic acid—Body temperature increased—Temozolomide—brain cancer	0.000237	0.00172	CcSEcCtD
Mefenamic acid—Abdominal pain—Temozolomide—brain cancer	0.000237	0.00172	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Etoposide—brain cancer	0.000235	0.00171	CcSEcCtD
Mefenamic acid—Tachycardia—Etoposide—brain cancer	0.000234	0.0017	CcSEcCtD
Mefenamic acid—Skin disorder—Etoposide—brain cancer	0.000233	0.0017	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000229	0.00648	CbGpPWpGaD
Mefenamic acid—Anorexia—Etoposide—brain cancer	0.000228	0.00166	CcSEcCtD
Mefenamic acid—Nausea—Hydroxyurea—brain cancer	0.000228	0.00166	CcSEcCtD
Mefenamic acid—Hypotension—Etoposide—brain cancer	0.000224	0.00163	CcSEcCtD
Mefenamic acid—Asthenia—Carmustine—brain cancer	0.000222	0.00162	CcSEcCtD
Mefenamic acid—Paraesthesia—Etoposide—brain cancer	0.000215	0.00157	CcSEcCtD
Mefenamic acid—Asthenia—Temozolomide—brain cancer	0.000215	0.00157	CcSEcCtD
Mefenamic acid—Dyspnoea—Etoposide—brain cancer	0.000214	0.00156	CcSEcCtD
Mefenamic acid—Somnolence—Etoposide—brain cancer	0.000213	0.00155	CcSEcCtD
Mefenamic acid—Diarrhoea—Carmustine—brain cancer	0.000212	0.00154	CcSEcCtD
Mefenamic acid—Pruritus—Temozolomide—brain cancer	0.000212	0.00154	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00021	0.00596	CbGpPWpGaD
Mefenamic acid—Decreased appetite—Etoposide—brain cancer	0.000208	0.00152	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Etoposide—brain cancer	0.000207	0.00151	CcSEcCtD
Mefenamic acid—Dizziness—Carmustine—brain cancer	0.000205	0.00149	CcSEcCtD
Mefenamic acid—Constipation—Etoposide—brain cancer	0.000205	0.00149	CcSEcCtD
Mefenamic acid—Diarrhoea—Temozolomide—brain cancer	0.000205	0.00149	CcSEcCtD
Mefenamic acid—PTGS1—ganglion—brain cancer	0.000203	0.0635	CbGeAlD
Mefenamic acid—AKR1C1—Signaling Pathways—OR4C12—brain cancer	0.000203	0.00574	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—OR14C36—brain cancer	0.000203	0.00574	CbGpPWpGaD
Mefenamic acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000201	0.00569	CbGpPWpGaD
Mefenamic acid—Dizziness—Temozolomide—brain cancer	0.000198	0.00144	CcSEcCtD
Mefenamic acid—Feeling abnormal—Etoposide—brain cancer	0.000197	0.00144	CcSEcCtD
Mefenamic acid—Vomiting—Carmustine—brain cancer	0.000197	0.00144	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Etoposide—brain cancer	0.000196	0.00143	CcSEcCtD
Mefenamic acid—Rash—Carmustine—brain cancer	0.000195	0.00142	CcSEcCtD
Mefenamic acid—Dermatitis—Carmustine—brain cancer	0.000195	0.00142	CcSEcCtD
Mefenamic acid—Headache—Carmustine—brain cancer	0.000194	0.00141	CcSEcCtD
Mefenamic acid—Vomiting—Temozolomide—brain cancer	0.00019	0.00139	CcSEcCtD
Mefenamic acid—Urticaria—Etoposide—brain cancer	0.00019	0.00139	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism—CYP2C9—brain cancer	0.00019	0.00537	CbGpPWpGaD
Mefenamic acid—Abdominal pain—Etoposide—brain cancer	0.000189	0.00138	CcSEcCtD
Mefenamic acid—Body temperature increased—Etoposide—brain cancer	0.000189	0.00138	CcSEcCtD
Mefenamic acid—Rash—Temozolomide—brain cancer	0.000189	0.00138	CcSEcCtD
Mefenamic acid—Dermatitis—Temozolomide—brain cancer	0.000189	0.00137	CcSEcCtD
Mefenamic acid—Headache—Temozolomide—brain cancer	0.000188	0.00137	CcSEcCtD
Mefenamic acid—PTGS2—Spinal Cord Injury—GFAP—brain cancer	0.000187	0.0053	CbGpPWpGaD
Mefenamic acid—Nausea—Carmustine—brain cancer	0.000184	0.00134	CcSEcCtD
Mefenamic acid—AKR1C1—Disease—HES5—brain cancer	0.000181	0.00512	CbGpPWpGaD
Mefenamic acid—AKR1C3—pituitary gland—brain cancer	0.00018	0.0564	CbGeAlD
Mefenamic acid—Nausea—Temozolomide—brain cancer	0.000178	0.0013	CcSEcCtD
Mefenamic acid—PTGS2—S1P1 pathway—VEGFA—brain cancer	0.000175	0.00496	CbGpPWpGaD
Mefenamic acid—PTGS1—endothelium—brain cancer	0.000175	0.0547	CbGeAlD
Mefenamic acid—AKR1C3—medulla oblongata—brain cancer	0.000174	0.0544	CbGeAlD
Mefenamic acid—AKR1C1—Signaling Pathways—DTX2—brain cancer	0.000172	0.00488	CbGpPWpGaD
Mefenamic acid—Asthenia—Etoposide—brain cancer	0.000172	0.00125	CcSEcCtD
Mefenamic acid—Pruritus—Etoposide—brain cancer	0.00017	0.00124	CcSEcCtD
Mefenamic acid—PTGS2—endothelium—brain cancer	0.000167	0.0523	CbGeAlD
Mefenamic acid—AKR1C3—Disease—DTX2—brain cancer	0.000166	0.00469	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	0.000164	0.00465	CbGpPWpGaD
Mefenamic acid—Diarrhoea—Etoposide—brain cancer	0.000164	0.00119	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism—BSG—brain cancer	0.000161	0.00457	CbGpPWpGaD
Mefenamic acid—PTGS1—blood vessel—brain cancer	0.000161	0.0505	CbGeAlD
Mefenamic acid—AKR1C3—midbrain—brain cancer	0.000159	0.0497	CbGeAlD
Mefenamic acid—Dizziness—Etoposide—brain cancer	0.000158	0.00115	CcSEcCtD
Mefenamic acid—AKR1C3—spinal cord—brain cancer	0.000155	0.0485	CbGeAlD
Mefenamic acid—PTGS2—blood vessel—brain cancer	0.000154	0.0483	CbGeAlD
Mefenamic acid—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000154	0.00436	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000154	0.00436	CbGpPWpGaD
Mefenamic acid—Vomiting—Etoposide—brain cancer	0.000152	0.00111	CcSEcCtD
Mefenamic acid—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000152	0.0043	CbGpPWpGaD
Mefenamic acid—Rash—Etoposide—brain cancer	0.000151	0.0011	CcSEcCtD
Mefenamic acid—Dermatitis—Etoposide—brain cancer	0.000151	0.0011	CcSEcCtD
Mefenamic acid—Headache—Etoposide—brain cancer	0.00015	0.00109	CcSEcCtD
Mefenamic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	0.000147	0.00416	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000146	0.00414	CbGpPWpGaD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.000143	0.00406	CbGpPWpGaD
Mefenamic acid—Nausea—Etoposide—brain cancer	0.000142	0.00104	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism—CYP2C9—brain cancer	0.000139	0.00394	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—IDH1—brain cancer	0.000139	0.00393	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—OR4C12—brain cancer	0.000136	0.00386	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—OR14C36—brain cancer	0.000136	0.00386	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PTCH2—brain cancer	0.000131	0.0037	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HES5—brain cancer	0.000126	0.00358	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—STRADA—brain cancer	0.000123	0.00348	CbGpPWpGaD
Mefenamic acid—AKR1C3—cerebellum—brain cancer	0.000123	0.0385	CbGeAlD
Mefenamic acid—AKR1C1—Disease—IDH1—brain cancer	0.000122	0.00344	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HES5—brain cancer	0.000122	0.00344	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—HES1—brain cancer	0.000121	0.00342	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—BSG—brain cancer	0.000118	0.00335	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	0.000116	0.00329	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—DTX2—brain cancer	0.000116	0.00329	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—HEY1—brain cancer	0.000115	0.00326	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—DLL1—brain cancer	0.000113	0.0032	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000113	0.0032	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000113	0.00319	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—ENO2—brain cancer	0.00011	0.00311	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ABR—brain cancer	0.000102	0.0029	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—IDH1—brain cancer	0.000102	0.00288	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000101	0.00285	CbGpPWpGaD
Mefenamic acid—AKR1C3—brain—brain cancer	9.97e-05	0.0312	CbGeAlD
Mefenamic acid—AKR1C1—Signaling Pathways—GLI2—brain cancer	9.9e-05	0.0028	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—SHH—brain cancer	9.61e-05	0.00272	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—ENO2—brain cancer	9.61e-05	0.00272	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	9.54e-05	0.0027	CbGpPWpGaD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	9.49e-05	0.00269	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CYP2C9—brain cancer	9.37e-05	0.00265	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—GLI1—brain cancer	9.31e-05	0.00264	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.15e-05	0.00259	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SUFU—brain cancer	8.82e-05	0.0025	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTCH2—brain cancer	8.79e-05	0.00249	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	8.62e-05	0.00244	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—GFAP—brain cancer	8.51e-05	0.00241	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HES5—brain cancer	8.51e-05	0.00241	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	8.44e-05	0.00239	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.29e-05	0.00235	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—STRADA—brain cancer	8.26e-05	0.00234	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IDH1—brain cancer	8.18e-05	0.00232	CbGpPWpGaD
Mefenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	8.1e-05	0.0023	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HEY1—brain cancer	8.07e-05	0.00229	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	8.05e-05	0.00228	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—ENO2—brain cancer	8.05e-05	0.00228	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—BSG—brain cancer	7.96e-05	0.00226	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	7.93e-05	0.00225	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—DLL1—brain cancer	7.91e-05	0.00224	CbGpPWpGaD
Mefenamic acid—CYP2C8—pituitary gland—brain cancer	7.85e-05	0.0246	CbGeAlD
Mefenamic acid—PTGS1—telencephalon—brain cancer	7.82e-05	0.0245	CbGeAlD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	7.76e-05	0.0022	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HEY1—brain cancer	7.75e-05	0.0022	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—DLL1—brain cancer	7.6e-05	0.00215	CbGpPWpGaD
Mefenamic acid—PTGS2—telencephalon—brain cancer	7.47e-05	0.0234	CbGeAlD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.27e-05	0.00206	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	7.23e-05	0.00205	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—CDK4—brain cancer	7.21e-05	0.00204	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—VAV1—brain cancer	6.94e-05	0.00197	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ABR—brain cancer	6.9e-05	0.00195	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—IDH1—brain cancer	6.85e-05	0.00194	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SHH—brain cancer	6.73e-05	0.00191	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	6.7e-05	0.0019	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.69e-05	0.0019	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—GLI2—brain cancer	6.66e-05	0.00189	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	6.61e-05	0.00187	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TRPC6—brain cancer	6.49e-05	0.00184	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	6.48e-05	0.00184	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—SHH—brain cancer	6.46e-05	0.00183	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—ENO2—brain cancer	6.46e-05	0.00183	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	6.4e-05	0.00181	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SMO—brain cancer	6.38e-05	0.00181	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PTCH1—brain cancer	6.38e-05	0.00181	CbGpPWpGaD
Mefenamic acid—PTGS1—pituitary gland—brain cancer	6.37e-05	0.0199	CbGeAlD
Mefenamic acid—AKR1C3—Signaling Pathways—GLI1—brain cancer	6.26e-05	0.00177	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	6.11e-05	0.00173	CbGpPWpGaD
Mefenamic acid—PTGS2—pituitary gland—brain cancer	6.08e-05	0.0191	CbGeAlD
Mefenamic acid—CYP2C8—endocrine gland—brain cancer	6.08e-05	0.0191	CbGeAlD
Mefenamic acid—AKR1C1—Disease—HES1—brain cancer	5.97e-05	0.00169	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	5.95e-05	0.00169	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SUFU—brain cancer	5.94e-05	0.00168	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.91e-05	0.00168	CbGpPWpGaD
Mefenamic acid—PTGS2—medulla oblongata—brain cancer	5.87e-05	0.0184	CbGeAlD
Mefenamic acid—AKR1C3—Signaling Pathways—GFAP—brain cancer	5.73e-05	0.00162	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—DTX2—brain cancer	5.72e-05	0.00162	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PDGFRA—brain cancer	5.68e-05	0.00161	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	5.67e-05	0.00161	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.58e-05	0.00158	CbGpPWpGaD
Mefenamic acid—PTGS1—spinal cord—brain cancer	5.48e-05	0.0172	CbGeAlD
Mefenamic acid—AKR1C3—Signaling Pathways—HEY1—brain cancer	5.43e-05	0.00154	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ENO2—brain cancer	5.41e-05	0.00153	CbGpPWpGaD
Mefenamic acid—CYP2C9—endocrine gland—brain cancer	5.4e-05	0.0169	CbGeAlD
Mefenamic acid—PTGS2—midbrain—brain cancer	5.37e-05	0.0168	CbGeAlD
Mefenamic acid—AKR1C3—Signaling Pathways—DLL1—brain cancer	5.32e-05	0.00151	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.31e-05	0.00151	CbGpPWpGaD
Mefenamic acid—PTGS2—spinal cord—brain cancer	5.24e-05	0.0164	CbGeAlD
Mefenamic acid—AKR1C1—Signaling Pathways—NOTCH2—brain cancer	5.1e-05	0.00144	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PIK3CG—brain cancer	5.03e-05	0.00142	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IRS2—brain cancer	4.99e-05	0.00141	CbGpPWpGaD
Mefenamic acid—PTGS1—endocrine gland—brain cancer	4.93e-05	0.0154	CbGeAlD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	4.9e-05	0.00139	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—MYC—brain cancer	4.9e-05	0.00139	CbGpPWpGaD
Mefenamic acid—PTGS1—head—brain cancer	4.87e-05	0.0153	CbGeAlD
Mefenamic acid—AKR1C1—Signaling Pathways—VAV1—brain cancer	4.86e-05	0.00138	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL2—brain cancer	4.77e-05	0.00135	CbGpPWpGaD
Mefenamic acid—PTGS2—endocrine gland—brain cancer	4.71e-05	0.0148	CbGeAlD
Mefenamic acid—AKR1C3—Disease—VAV1—brain cancer	4.67e-05	0.00132	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—CCND1—brain cancer	4.65e-05	0.00132	CbGpPWpGaD
Mefenamic acid—PTGS2—head—brain cancer	4.65e-05	0.0146	CbGeAlD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	4.61e-05	0.00131	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SHH—brain cancer	4.53e-05	0.00128	CbGpPWpGaD
Mefenamic acid—PTGS1—central nervous system—brain cancer	4.44e-05	0.0139	CbGeAlD
Mefenamic acid—AKR1C1—Disease—APC—brain cancer	4.41e-05	0.00125	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TRPC6—brain cancer	4.37e-05	0.00124	CbGpPWpGaD
Mefenamic acid—CYP2C8—brain—brain cancer	4.35e-05	0.0136	CbGeAlD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.32e-05	0.00123	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SMO—brain cancer	4.29e-05	0.00122	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTCH1—brain cancer	4.29e-05	0.00122	CbGpPWpGaD
Mefenamic acid—PTGS2—central nervous system—brain cancer	4.25e-05	0.0133	CbGeAlD
Mefenamic acid—PTGS2—Disease—HES5—brain cancer	4.2e-05	0.00119	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HES1—brain cancer	4.18e-05	0.00118	CbGpPWpGaD
Mefenamic acid—PTGS2—cerebellum—brain cancer	4.15e-05	0.013	CbGeAlD
Mefenamic acid—PTGS1—Metabolism—CYP2C9—brain cancer	4.08e-05	0.00116	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HES1—brain cancer	4.02e-05	0.00114	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PDGFRA—brain cancer	3.98e-05	0.00113	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SPP1—brain cancer	3.86e-05	0.00109	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PDGFRA—brain cancer	3.82e-05	0.00108	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MYC—brain cancer	3.73e-05	0.00106	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PIK3CG—brain cancer	3.69e-05	0.00105	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—EGFR—brain cancer	3.65e-05	0.00103	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.58e-05	0.00102	CbGpPWpGaD
Mefenamic acid—PTGS1—brain—brain cancer	3.53e-05	0.0111	CbGeAlD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.52e-05	0.000997	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IRS2—brain cancer	3.49e-05	0.00099	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—BSG—brain cancer	3.47e-05	0.000982	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOTCH2—brain cancer	3.43e-05	0.000972	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—ERBB2—brain cancer	3.42e-05	0.00097	CbGpPWpGaD
Mefenamic acid—PTGS2—brain—brain cancer	3.37e-05	0.0106	CbGeAlD
Mefenamic acid—AKR1C3—Disease—IRS2—brain cancer	3.36e-05	0.000951	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VAV1—brain cancer	3.27e-05	0.000927	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP2C9—brain cancer	3.24e-05	0.000917	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.17e-05	0.000897	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.13e-05	0.000888	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CG—brain cancer	3.09e-05	0.000875	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—APC—brain cancer	3.09e-05	0.000875	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TP53—brain cancer	3.07e-05	0.000869	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CTNNB1—brain cancer	2.99e-05	0.000848	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—IDH1—brain cancer	2.98e-05	0.000845	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—APC—brain cancer	2.97e-05	0.00084	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IDH1—brain cancer	2.83e-05	0.000801	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HES1—brain cancer	2.81e-05	0.000797	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.76e-05	0.000782	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—BSG—brain cancer	2.75e-05	0.00078	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HEY1—brain cancer	2.68e-05	0.000759	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PDGFRA—brain cancer	2.68e-05	0.000759	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP2C9—brain cancer	2.63e-05	0.000746	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—DLL1—brain cancer	2.63e-05	0.000744	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—STAT3—brain cancer	2.61e-05	0.00074	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SPP1—brain cancer	2.6e-05	0.000737	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.54e-05	0.00072	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.48e-05	0.000704	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CG—brain cancer	2.48e-05	0.000704	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.43e-05	0.000688	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MYC—brain cancer	2.42e-05	0.000687	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—RELA—brain cancer	2.41e-05	0.000683	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ERBB2—brain cancer	2.4e-05	0.000679	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EGFR—brain cancer	2.37e-05	0.000672	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—IDH1—brain cancer	2.37e-05	0.000671	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ENO2—brain cancer	2.36e-05	0.000668	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IRS2—brain cancer	2.35e-05	0.000666	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—ERBB2—brain cancer	2.3e-05	0.000652	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—BSG—brain cancer	2.24e-05	0.000635	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ENO2—brain cancer	2.23e-05	0.000633	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SHH—brain cancer	2.23e-05	0.000633	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL2—brain cancer	2.17e-05	0.000615	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCND1—brain cancer	2.12e-05	0.0006	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CTNNB1—brain cancer	2.1e-05	0.000594	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.09e-05	0.000591	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APC—brain cancer	2.08e-05	0.000588	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CG—brain cancer	2.08e-05	0.000588	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CTNNB1—brain cancer	2.01e-05	0.000571	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.93e-05	0.000546	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—IDH1—brain cancer	1.93e-05	0.000546	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ENO2—brain cancer	1.87e-05	0.00053	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—brain cancer	1.85e-05	0.000523	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—STAT3—brain cancer	1.83e-05	0.000518	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—BSG—brain cancer	1.82e-05	0.000516	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—STAT3—brain cancer	1.76e-05	0.000498	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MYC—brain cancer	1.7e-05	0.000481	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EGFR—brain cancer	1.66e-05	0.000471	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MYC—brain cancer	1.63e-05	0.000462	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—RELA—brain cancer	1.62e-05	0.00046	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—VAV1—brain cancer	1.61e-05	0.000457	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ERBB2—brain cancer	1.61e-05	0.000457	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EGFR—brain cancer	1.6e-05	0.000452	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.57e-05	0.000444	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—IDH1—brain cancer	1.57e-05	0.000444	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ENO2—brain cancer	1.52e-05	0.000431	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL2—brain cancer	1.46e-05	0.000414	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCND1—brain cancer	1.42e-05	0.000404	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CTNNB1—brain cancer	1.41e-05	0.0004	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—brain cancer	1.39e-05	0.000395	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HES1—brain cancer	1.39e-05	0.000393	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PDGFRA—brain cancer	1.32e-05	0.000374	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.28e-05	0.000362	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—brain cancer	1.24e-05	0.000352	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ENO2—brain cancer	1.24e-05	0.000351	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—STAT3—brain cancer	1.23e-05	0.000348	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IRS2—brain cancer	1.16e-05	0.000329	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MYC—brain cancer	1.14e-05	0.000324	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGFR—brain cancer	1.12e-05	0.000317	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CG—brain cancer	1.08e-05	0.000306	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APC—brain cancer	1.02e-05	0.00029	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—brain cancer	9.38e-06	0.000266	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CG—brain cancer	8.58e-06	0.000243	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ERBB2—brain cancer	7.96e-06	0.000225	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CG—brain cancer	6.98e-06	0.000198	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CTNNB1—brain cancer	6.96e-06	0.000197	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—STAT3—brain cancer	6.07e-06	0.000172	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CG—brain cancer	5.68e-06	0.000161	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MYC—brain cancer	5.64e-06	0.00016	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGFR—brain cancer	5.52e-06	0.000156	CbGpPWpGaD
